beta-Blockers in heart failure: clinical applications. JAMA 2002 Feb 20;287(7):890-7
Date
02/20/2002Pubmed ID
11851583DOI
10.1001/jama.287.7.890Scopus ID
2-s2.0-0037138798 (requires institutional sign-in at Scopus site) 50 CitationsAbstract
beta-Blockers reduce morbidity and mortality in heart failure patients with left ventricular systolic dysfunction and stable fluid status. The successful adoption of beta-blocker guidelines for these patients requires an understanding of the value of this therapy and effective systems to maintain safety and ensure high quality of care. This article distills scientific evidence and consensus guidelines into a series of cases and practical answers about patient selection, discussions with patients, management and monitoring, and systems improvements to optimize quality of care, safety, and benefit for all patients with heart failure.
Author List
Farrell MH, Foody JM, Krumholz HMMESH terms used to index this publication - Major topics in bold
Adrenergic beta-AntagonistsAdult
Aged
Aged, 80 and over
Clinical Trials as Topic
Female
Heart Failure
Humans
Male
Middle Aged
Patient Selection
Practice Guidelines as Topic
Ventricular Dysfunction, Left